Figure 3From: Tolerability to romidepsin in patients with relapsed/refractory T-cell lymphoma Thrombocytopenia recovery by cycle of romidepsin treatment for patients with relapsed/refractory peripheral T-cell lymphoma (A) or cutaneous (B) T-cell lymphoma. BL, baseline; C, cycle, D, day.Back to article page